Table 2.
Variable | SISTER Trial | TOMUS Trial | ||||
---|---|---|---|---|---|---|
Normal | Overweight | Obese | Normal | Overweight | Obese | |
Resting angle 1 | 8.8(15.0) | 14.9(15.6) | 19.0(19.5)*** | 6.7(13.0) | 5.5(11.7) | 11.8(13.5)*** |
Strain angle1 | 59.2(18.8) | 60.0(17.8) | 60.8(18.4) | 46.9(20.2) | 44.7(21.5) | 46.5(20.5) |
Delta1 | 50.5(18.0) | 45.1(17.6) | 41.7(18.1)*** | 40.3(18.7) | 39.2(20.5) | 34.7(17.9)** |
POP-Q [N(%)] 2 | ||||||
Stages 0–I | 33 (23%) | 54 (25%) | 74 (26%) | 64 (47%) | 82 (43%) | 120 (46%) |
Stage II | 85 (60%) | 119 (55%) | 180 (62%) | 60 (44%) | 93 (48%) | 124 (47%) |
Stage III | 24 (17%) | 45 (21%) | 36 (12%) | 13 (9%) | 17 (9%) | 18 (7%) |
Point Ba1 | −0.4(2.1) | −0.4(2.0) | −0.8(1.6)* | −1.2(1.5) | −1.2(1.8) | −1.4 (1.3) |
Point Bp1 | −1.7(1.8) | −1.6(1.7) | −1.7(1.4) | −1.9(1.3) | −1.8(1.8) | −2.0 (1.1) |
Point Gh1 | 3.5(1.0) | 3.5(1.3) | 3.7(1.2) | 3.3(1.0) | 3.4(1.0) | 3.6(1.1)* |
Brink score 1 | 9.1(2.0) | 8.9(2.2) | 8.9(2.0) | 8.9(1.8) | 8.7(2.1) | 8.7 (2.0) |
Mean and SD were presented except POP-Q;
Equality of means tested by ANOVA
Equality of frequencies tested by Chi-square
0.01≤P< 0.05
0.001≤ P <0.01
P<0.001